Question 1

What is the catalog number for 2β,6β,15α-Trihydroxy-ent-kaur-16-ene?

Accepted Answer

The catalog number for 2β,6β,15α-Trihydroxy-ent-kaur-16-ene is DCA45232.

Question 2

What sizes are available for 2β,6β,15α-Trihydroxy-ent-kaur-16-ene?

Accepted Answer

2β,6β,15α-Trihydroxy-ent-kaur-16-ene is available in the following size(s): 1 mg, 5 mg, 10 mg, 25 mg, 50 mg.

Question 3

How many pack sizes does 2β,6β,15α-Trihydroxy-ent-kaur-16-ene come in?

Accepted Answer

2β,6β,15α-Trihydroxy-ent-kaur-16-ene is available in 5 different pack sizes.

Question 4

Is 2β,6β,15α-Trihydroxy-ent-kaur-16-ene in stock?

Accepted Answer

2β,6β,15α-Trihydroxy-ent-kaur-16-ene is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Question 6

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 7

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

2β,6β,15α-Trihydroxy-ent-kaur-16-ene

Product Specifications

CAS Number

MDL Number

Smiles

Molecular Formula

Molecular Weight

Controlled

Available Sizes

Frequently Asked Questions

Explore Other Products

TAG-72 / CA72.4 (Tumor-Associated Glycoprotein) (rB72.3), CF740 conjugate, 0.1mg/mL

rac Xanthoanthrafil (>90%)

ELP4 antibody

Human DEFB116 activation kit by CRISPRa

Tissue Genomic DNA, Breast

IL2 Antibody